Avalon Capital Management’s Merck MRK Stock Holding History

Avalon Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,604	Closed	-$657K	–	148
2024 Q4	$657K	Sell	6,604 -250	-4%	-$25.8K	0.21%	73
2024 Q3	$778K	Sell	6,854 -1,640	-19%	-$195K	0.24%	64
2024 Q2	$1.05M	Buy	8,494 +2,133	+34%	+$275K	0.33%	49
2024 Q1	$839K	Hold	6,361	–	–	0.34%	36
2023 Q4	$693K	Hold	6,361	–	–	0.29%	44
2023 Q3	$655K	Buy	6,361 +1,000	+19%	+$108K	0.33%	30
2023 Q2	$619K	Hold	5,361	–	–	0.29%	32
2023 Q1	$570K	Sell	5,361 -140	-3%	-$15.1K	0.29%	33
2022 Q4	$610K	Buy	5,501 +168	+3%	+$17.2K	0.31%	30
2022 Q3	$459K	Buy	5,333 +177	+3%	+$15.8K	0.22%	34
2022 Q2	$470K	Buy	5,156 +115	+2%	+$10.2K	0.19%	37
2022 Q1	$447K	Buy	+5,041	New	+$397K	0.17%	44
2014 Q2	–	Sell	-18,983	Closed	-$1.03M	–	106
2014 Q1	$1.03M	Buy	+18,983	New	+$983K	0.83%	47

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Avalon Capital Management's MRK Position: Q1 2025 in Review

Avalon Capital Management sold out of Merck (MRK) in Q1 2025, closing a stake of 6,604 shares — an estimated $657K sold.

Avalon Capital Management first reported a position in MRK in Q1 2014 and held it in 13 quarters. The position peaked at $1.05M in Q2 2024. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

Avalon Capital Management reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
Avalon Capital Management sold 6,604 Merck shares in Q1 2025, an estimated $657K.
Avalon Capital Management first reported a position in Merck in Q1 2014 and held it in 13 quarters.
Avalon Capital Management's Merck position peaked at $1.05M in Q2 2024.
3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Avalon Capital Management's 13F filing for Q1 2025, filed 7 May 2025.